about
Inhibition of 4EBP phosphorylation mediates the cytotoxic effect of mechanistic target of rapamycin kinase inhibitors in aggressive B-cell lymphomasDiffuse large B-cell lymphoma: can genomics improve treatment options for a curable cancer?Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinomaCardiovascular disease after cancer therapy.Targeting lymphoma with precision using semisynthetic anti-idiotype peptibodiesFatal Hepatocellular Carcinoma in a Patient with Occult Hepatitis B Virus Infection following the Administration of R-CHOP for Diffuse Large B-Cell LymphomaIncreasing and worsening late effects in childhood cancer survivors during follow-up.A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands.Protocol for Care After Lymphoma (CALy) trial: a phase II pilot randomised controlled trial of a lymphoma nurse-led model of survivorship careAsymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance.Stomach cancer risk after treatment for hodgkin lymphoma.ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.Appropriate surveillance for late complications in patients in remission from Hodgkin lymphoma.Precision therapy for lymphoma--current state and future directions.Evolution of lymphoma staging and response evaluation: current limitations and future directions.Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: ReDisparities in conditional net survival among non-Hodgkin lymphoma survivors: a population-based analysis.Quality of life amongst lymphoma survivors in a developing country.Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region.Role of oncologists and primary care physicians in providing follow-up care to non-Hodgkin lymphoma survivors within 5 years of diagnosis: a population-based study.A Rare Differential Diagnosis of an Adrenal Mass: A Case Report.The course of anxiety and depression for patients with Hodgkin's lymphoma or diffuse large B cell lymphoma: a longitudinal study of the PROFILES registry.Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study.Neoplasms and infections as the main causes of death in patients in complete response to HIV-related non-Hodgkin lymphoma in the combination antiretroviral therapy era: a study out of a series of 146 patients.Nonmyeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenstrom macroglobulinemia: Evidence for a graft-versus-lymphoma effect.Auto- versus human-driven plan in mediastinal Hodgkin lymphoma radiation treatmentLong-term risk of cardiovascular mortality in lymphoma survivors: A systematic review and meta-analysis
P2860
Q33574190-8F90603A-62D9-4463-A767-59769CD5A3AAQ33622342-12FD6F5A-0103-4BFB-9CEA-C80EFCA86D41Q33900752-77B0A204-A293-4FB2-B88B-A8DF0C14A977Q34604429-6B52FAB1-A6A5-4CBB-A526-CE40C8B6A6F7Q35999110-D69B2068-7AD6-4B68-9F8F-2B3A0DAF5781Q36522482-A743EEBE-D638-4256-9983-C6147AA2B706Q36841132-DCEDFB50-CB0A-4E3F-8460-83E5C430BAE9Q36862345-FE5FD2D7-CDCC-4161-BA4A-4E4AD587F974Q36920190-A1BC92AE-BD15-4274-B00D-05F125334DEFQ36939536-027CE12A-71CD-4330-9125-1AA31E06F2F2Q37165088-60510EDD-26D3-47D7-A8B5-CF6693717765Q37598106-60C7E0B0-AE79-4BEE-A354-B0B1D258BC29Q38022455-347DEAA6-DB0A-4F8D-B620-0D1A5FAF1AC0Q38241102-7D146251-A953-49F3-B48B-6D44A550CBE6Q38671671-3056F2C0-F94C-49FE-8C97-E494038A6CBCQ40375360-F1E75FB2-A461-4C11-8FC8-41B25F69A335Q40476175-8C406AA7-E96F-4A22-9343-96A3A4FB7B6AQ40513610-585B919C-57FF-4C16-AA4B-1D15760F79F6Q41270677-A7B33225-98CC-43C3-B1D3-45A296F1D513Q46929912-9C60F7AD-A7D2-4FC2-8B58-B917C950E2D5Q47154442-52D4C594-7B0C-419F-A33F-2166E80BDAEDQ47876832-64E81BCD-F13F-4F05-BCB3-5ADAAB46238BQ48100075-75B50F8E-F134-4E6D-98A4-1D760959F169Q51876645-01089711-503B-46F3-A001-3C8CDF1C8924Q54419189-5CBB5ECA-D0F4-4746-B530-86791CF99FF2Q57811275-5F88355D-4D1A-47E3-B084-FCE417884D27Q58775872-206156B5-399A-4247-80FF-DD0864C73E78
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term complications of lymphoma and its treatment.
@en
Long-term complications of lymphoma and its treatment.
@nl
type
label
Long-term complications of lymphoma and its treatment.
@en
Long-term complications of lymphoma and its treatment.
@nl
prefLabel
Long-term complications of lymphoma and its treatment.
@en
Long-term complications of lymphoma and its treatment.
@nl
P2093
P356
P1476
Long-term complications of lymphoma and its treatment.
@en
P2093
Andrea K Ng
Ann LaCasce
Lois B Travis
P304
P356
10.1200/JCO.2010.32.8427
P407
P577
2011-04-11T00:00:00Z